Page last updated: 2024-09-03

4-hydroxymephenytoin and pantoprazole

4-hydroxymephenytoin has been researched along with pantoprazole in 1 studies

Compound Research Comparison

Studies
(4-hydroxymephenytoin)
Trials
(4-hydroxymephenytoin)
Recent Studies (post-2010)
(4-hydroxymephenytoin)
Studies
(pantoprazole)
Trials
(pantoprazole)
Recent Studies (post-2010) (pantoprazole)
36501,467476579

Protein Interaction Comparison

ProteinTaxonomy4-hydroxymephenytoin (IC50)pantoprazole (IC50)
Solute carrier family 22 member 2Homo sapiens (human)1.5
Multidrug and toxin extrusion protein 1Homo sapiens (human)2.8
Broad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)7.75

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hakusui, H; Ishizaki, T; Kaneko, S; Ohkubo, T; Otani, K; Ryokawa, Y; Sugawara, K; Suzuki, A; Tanaka, M; Yamamori, S1

Other Studies

1 other study(ies) available for 4-hydroxymephenytoin and pantoprazole

ArticleYear
Metabolic disposition of pantoprazole, a proton pump inhibitor, in relation to S-mephenytoin 4'-hydroxylation phenotype and genotype.
    Clinical pharmacology and therapeutics, 1997, Volume: 62, Issue:6

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Half-Life; Humans; Japan; Male; Mephenytoin; Metabolic Clearance Rate; Mixed Function Oxygenases; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides

1997